Is routine endocrine testing of impotent men necessary?

Area of Science:

• Urology
• Endocrinology
• Men's Health

Background:

• Endocrine screening aims to find treatable causes of impotence.
• The prevalence of endocrinopathy in impotent men is generally low.
• Cost-effective screening strategies are needed for endocrine evaluation in impotence.

Purpose of the Study:

• To identify historical or physical findings that predict endocrinopathy in impotent men.
• To reduce the cost of endocrine screening by targeting at-risk patients.

Main Methods:

• Retrospective analysis of endocrine screening results from 330 impotent patients.
• Evaluation of historical data and physical examination findings.
• Correlation of findings with diagnosed endocrinopathy.

Main Results:

• Only 7 patients (2.1%) were diagnosed with endocrinopathy.
• Decreased libido was reported by 6 patients, and testicular atrophy by 5.
• All endocrinopathy cases presented with either decreased libido or bilateral testicular atrophy.

Conclusions:

• Clinical signs of hypogonadism, specifically decreased libido or bilateral testicular atrophy, can identify impotent men at risk for endocrinopathy.
• Targeted endocrine screening based on these clinical signs can decrease the cost of impotence evaluation.
• Routine endocrine screening may not be necessary for all impotent men.